Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives

1. F. P. Schmidtchen and M. Berger, Artificial organic host molecules for anions, Chem. Rev.97 (1997) 1609–1646; DOI: 10.1021/cr9603845.10.1021/cr9603845Search in Google Scholar

2. U. E. W. Lange, D. Baucke, W. Hornberger, H. Mack, W. Seitz and H. W. Höffken, D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety, Bioorg. Med. Chem. Lett.13 (2003) 2029–2033; DOI: 10.1016/S0960-894X(03)00347-0.10.1016/S0960-894X(03)00347-0Search in Google Scholar

3. J. L. Jiménez Blanco, P. Bootello, J. M. Benito, C. O. Mellet and J. M. García Fernandez, Urea-, thiourea-, and guanidine-linked glycooligomers as phosphate binders in water, J. Org. Chem.71 (2006) 5136–5143; DOI: 10.1021/jo060360q.10.1021/jo060360qSearch in Google Scholar

4. S. Ekelund, P. Nygren and R. Larsson, Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology, Biochem. Pharmacol.61 (2001) 1183–1193; DOI: 10.1016/S0006-2952(01)00570-6.10.1016/S0006-2952(01)00570-6Search in Google Scholar

5. A. Andreani, M. Granaiola, A. Leoni, A. Locatelli, R. Morigi, M. Rambaldi, G. Lenaz, R. Fato, C. Bergamini and G. Farruggia, Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2’,3’:2,3]imidazo[4,5-c]quinoline, J. Med. Chem.48 (2005) 3085–3089; DOI: 10.1021/jm040888s.10.1021/jm040888sSearch in Google Scholar

6. A. L. LaFrate, J. R. Gunther, K. E. Carlson and J. A. Katzenellenbogen, Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor, Bioorg. Med. Chem.16 (2008) 10075–10084; DOI: 10.1016/j.bmc.2008.10.007.10.1016/j.bmc.2008.10.007Search in Google Scholar

7. P. Ulrich and A. Cerami, Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analogues, J. Med. Chem.27 (1984) 35–40; DOI: 10.1021/jm00367a007.10.1021/jm00367a007Search in Google Scholar

8. J. R. Ring, F. Zheng, A. J. Haubner, J. M. Littleton and P. A Crooks, Improving the inhibitory activity of arylidenaminoguanidine compounds at the N-methyl-D-aspartate receptor complex from a recursive computational-experimental structure-activity relationship study, Bioorg. Med. Chem.21 (2013) 1764–1774; DOI: 10.1016/j.bmc.2013.01.051.10.1016/j.bmc.2013.01.051Search in Google Scholar